Virta Health sits at No. 448 in our ranking with a Brief Score of 55. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.
Prefer a straight head-to-head? CoreAge Rx vs Virta Health.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
The only program tracked here that commits in writing to not using an intro rate — and the arithmetic on its own page backs the promise.
Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.
Identical $199 pricing on both molecules, an oral route, LegitScript-certified and nationwide.
FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.
The widest published catalog in our ranking (telosrx.com): compounded semaglutide and tirzepatide in oral and microdosed forms, plus intranasal NAD+, recovery peptides and bioidentical HRT — all compounded, none FDA-approved, on a LegitScript-certified platform.
A LegitScript-certified, app-adjacent program with an oral option and mid-market pricing nationwide.
A nationwide provider with an oral option — full-formulary, but priced at the premium end.
Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.